These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 11498218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B, Sablé-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O, LeHoang P, Piette JC.
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH, Kwok SK, Seo SH, Yoon CH, Kim HY, Park SH.
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [Abstract] [Full Text] [Related]

  • 6. Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients.
    Katsiari CG, Theodossiadis PG, Kaklamanis PG, Markomichelakis NN, Sfikakis PP.
    Adv Exp Med Biol; 2003 Aug; 528():551-5. PubMed ID: 12918762
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-TNF-alpha therapy for sight threatening uveitis.
    Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM.
    Br J Ophthalmol; 2005 May; 89(5):533-6. PubMed ID: 15834077
    [Abstract] [Full Text] [Related]

  • 10. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
    Jpn J Ophthalmol; 2007 May; 51(3):191-6. PubMed ID: 17554481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G.
    J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958
    [Abstract] [Full Text] [Related]

  • 13. [Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease].
    Tanaka H, Sugita S, Yamada Y, Kawaguchi T, Iwanaga Y, Kamoi K, Yokota M, Takase H, Mochizuki M.
    Nippon Ganka Gakkai Zasshi; 2010 Feb; 114(2):87-95. PubMed ID: 20187505
    [Abstract] [Full Text] [Related]

  • 14. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.
    Giansanti F, Barbera ML, Virgili G, Pieri B, Emmi L, Menchini U.
    Eur J Ophthalmol; 2004 Feb; 14(5):445-8. PubMed ID: 15506610
    [Abstract] [Full Text] [Related]

  • 15. Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet's disease by infliximab treatment.
    Takeuchi M, Harimoto K, Taguchi M, Sakurai Y.
    BMC Ophthalmol; 2015 Dec 12; 15():177. PubMed ID: 26653575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G, Jovanović S, Veselinović D, Zivković M.
    Vojnosanit Pregl; 2012 Feb 12; 69(2):168-74. PubMed ID: 22500372
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
    Triolo G, Vadalà M, Accardo-Palumbo A, Ferrante A, Ciccia F, Giardina E, Citarrella P, Lodato G, Licata G.
    Ann Rheum Dis; 2002 Jun 12; 61(6):560-1. PubMed ID: 12006336
    [No Abstract] [Full Text] [Related]

  • 19. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N, Parc C, Scavennec R, Dhôte R, Brézin AP, Guillevin L.
    Presse Med; 2005 Jul 23; 34(13):916-8. PubMed ID: 16142147
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease.
    Abu El-Asrar AM, Abboud EB, Aldibhi H, Al-Arfaj A.
    Int Ophthalmol; 2005 Jun 23; 26(3):83-92. PubMed ID: 17031510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.